Ip Tim Lau

727 total citations
11 papers, 253 citations indexed

About

Ip Tim Lau is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Genetics. According to data from OpenAlex, Ip Tim Lau has authored 11 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Epidemiology and 4 papers in Genetics. Recurrent topics in Ip Tim Lau's work include Diabetes and associated disorders (3 papers), Chronic Disease Management Strategies (3 papers) and Diabetes Management and Research (3 papers). Ip Tim Lau is often cited by papers focused on Diabetes and associated disorders (3 papers), Chronic Disease Management Strategies (3 papers) and Diabetes Management and Research (3 papers). Ip Tim Lau collaborates with scholars based in China, Hong Kong and Australia. Ip Tim Lau's co-authors include Ming Wai Yeung, Silvana Pannain, Joachim Pohlenz, Samuel Refetoff, Roy E. Weiss, Paolo Emidio Macchia, Peter C.Y. Tong, Wing‐Yee So, Man-Wo Tsang and Wilson Y.S. Leung and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Journal of Cardiovascular Pharmacology.

In The Last Decade

Ip Tim Lau

11 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ip Tim Lau China	7	203	54	36	34	30	11	253
Janne Kytö Finland	7	109 0.5×	33 0.6×	27 0.8×	20 0.6×	48 1.6×	10	244
Kyaw Soe United States	7	119 0.6×	30 0.6×	25 0.7×	40 1.2×	26 0.9×	18	228
Nicole Aumann Germany	7	115 0.6×	76 1.4×	17 0.5×	41 1.2×	18 0.6×	8	236
Stefan Mutter Finland	8	80 0.4×	52 1.0×	22 0.6×	35 1.0×	35 1.2×	24	222
H. Lehnert Germany	6	81 0.4×	84 1.6×	64 1.8×	24 0.7×	72 2.4×	14	284
Liying Guan China	10	150 0.7×	106 2.0×	11 0.3×	31 0.9×	15 0.5×	17	263
Maija Feodoroff Finland	8	157 0.8×	30 0.6×	62 1.7×	11 0.3×	61 2.0×	10	232
Kerri P. Howard United States	8	37 0.2×	37 0.7×	23 0.6×	41 1.2×	17 0.6×	15	289
Yutaka Susuta Japan	8	254 1.3×	28 0.5×	17 0.5×	115 3.4×	20 0.7×	15	339
Jong Ha Baek South Korea	9	95 0.5×	33 0.6×	10 0.3×	20 0.6×	24 0.8×	20	165

Countries citing papers authored by Ip Tim Lau

Since Specialization

Citations

This map shows the geographic impact of Ip Tim Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ip Tim Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ip Tim Lau more than expected).

Fields of papers citing papers by Ip Tim Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ip Tim Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ip Tim Lau. The network helps show where Ip Tim Lau may publish in the future.

Co-authorship network of co-authors of Ip Tim Lau

This figure shows the co-authorship network connecting the top 25 collaborators of Ip Tim Lau. A scholar is included among the top collaborators of Ip Tim Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ip Tim Lau. Ip Tim Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Yuen, Wai–Cheung, et al.. (2021). Unilateral adrenalectomy for aldosterone‐producing adenoma in Hong Kong: Outcomes and factors predicting resolution of hypertension. Surgical Practice. 25(3). 138–145. 2 indexed citations

Lau, Ip Tim, et al.. (2017). Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus. Diabetes Metabolic Syndrome and Obesity. Volume 10. 273–284. 21 indexed citations

Lau, Ip Tim. (2017). A Clinical Practice Guideline to Guide a System Approach to Diabetes Care in Hong Kong. Diabetes & Metabolism Journal. 41(2). 81–81. 40 indexed citations

Lau, Ip Tim, et al.. (2017). Effect of Initiation of Basal Insulin Glargine on Glycemic Control in Patients with Diabetes: Real Life Experience from Hong Kong. Journal of Diabetes Mellitus. 7(3). 108–120. 1 indexed citations

Lau, Ip Tim, et al.. (2014). An unusual cause of acromegaly. Hong Kong Medical Journal. 20(4). 331–334. 3 indexed citations

Chao, David Vai Kiong, et al.. (2013). Review on the use of insulin in primary care.. PubMed. 19(1). 52–60. 2 indexed citations

Ko, Gary T.C., CK Yeung, Wai‐Hang Leung, et al.. (2011). Cost implication of team-based structured versus usual care for type 2 diabetic patients with chronic renal disease.. PubMed. 17 Suppl 6. 9–12. 7 indexed citations

Li, June K.Y., et al.. (2009). Usage of a fixed dose of radioactive iodine for the treatment of hyperthyroidism: one-year outcome in a regional hospital in Hong Kong.. PubMed. 15(4). 267–73. 8 indexed citations

Chan, Juliana C.N., Wing‐Yee So, Chun‐Yip Yeung, et al.. (2009). Effects of Structured Versus Usual Care on Renal Endpoint in Type 2 Diabetes: The SURE Study. Diabetes Care. 32(6). 977–982. 89 indexed citations

10.

Pohlenz, Joachim, Roy E. Weiss, Paolo Emidio Macchia, et al.. (1999). Five New Families with Resistance to Thyroid Hormone not Caused by Mutations in the Thyroid Hormone Receptor β Gene¹. The Journal of Clinical Endocrinology & Metabolism. 84(11). 3919–3928. 70 indexed citations

11.

Lau, Ip Tim, K. Willey, Lynda Molyneaux, et al.. (1998). Does Insulin Therapy Have a Hypertensive Effect in Type 2 Diabetes?. Journal of Cardiovascular Pharmacology. 32(1). 39–41. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact